Shares of Bio-Techne Corp. rallied 5.67% to $63.03 Monday, on what proved to be an all-around favorable trading session for ...

After diving over 17% on January 2, shares in biopharma company Intelligent Bio Solutions ($INBS) are back with a rally, ...

Shares of Adicet Bio are trading lower after the clinical stage biotechnology company announced a one-for-16 reverse stock split.

Instil Bio stock falls after the company ends development of its lead cancer drug and exits a licensing deal, raising new ...

Investing.com -- Instil Bio (NASDAQ:TIL) stock fell 15% Tuesday after the company announced that its wholly-owned subsidiary Axion Bio has decided to discontinue clinical development of AXN-2510 and ...

If a little bird told you to think about buying Bluebird Bio (NASDAQ: BLUE) stock recently, there's a lot of information you'll need to evaluate. Between the new product that this small biotech has ...

Nuvation Bio enrolled the first patient in a late-stage study of Ibtrozi. The bigger story, though, was a Wall Street analyst's initiation of coverage on the stock. Shares of Nuvation Bio (NYSE: NUVB) ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

Bio-Rad Laboratories, Inc. is a multinational manufacturer and distributor of life science research and clinical diagnostics products. The company's stock has been underperforming due to various ...

Investing.com -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) stock fell 21.3% in after-hours trading Wednesday following the company’s announcement of a $10 million private placement with two ...

Bluebird Bio is short on capital and has major new expenses to cover. Meanwhile, its pipeline of drug candidates is looking very weak. Even if it can navigate the next two years, its growth will be ...